These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 11245451

  • 1. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
    Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, Bean J, Zheng T, Cooper D, Friedman C, Goodwin WJ.
    Cancer Res; 2001 Feb 15; 61(4):1457-63. PubMed ID: 11245451
    [Abstract] [Full Text] [Related]

  • 2. Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.
    Mayne ST, Walter M, Cartmel B, Goodwin WJ, Blumberg J.
    Nutr Cancer; 2004 Feb 15; 49(1):1-6. PubMed ID: 15454352
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
    Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, Vigneault E, Vass S, del Vecchio P, Roy J.
    J Natl Cancer Inst; 2005 Apr 06; 97(7):481-8. PubMed ID: 15812073
    [Abstract] [Full Text] [Related]

  • 4. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):441-50. PubMed ID: 16595780
    [Abstract] [Full Text] [Related]

  • 5. beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial.
    Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, Giordano C, Benazzo M, Caroggio A, Cavalot AL, Gandolfo S, Garozzo A, Margarino G, Schenone G, Spadini N, Zibordi F, Balzarini F, Serafini I, Miani P, Cortesina G.
    Oncol Rep; 2003 Apr 05; 10(6):1895-901. PubMed ID: 14534715
    [Abstract] [Full Text] [Related]

  • 6. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK.
    Cancer Epidemiol Biomarkers Prev; 2001 Aug 05; 10(8):823-9. PubMed ID: 11489748
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
    Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Abdous B, Vigneault E, Vass S, Del Vecchio P, Roy J.
    J Clin Oncol; 2005 Aug 20; 23(24):5805-13. PubMed ID: 16027437
    [Abstract] [Full Text] [Related]

  • 8. Chemoprevention of head and neck cancer with retinoids: a negative result.
    Perry CF, Stevens M, Rabie I, Yarker ME, Cochrane J, Perry E, Traficante R, Coman W.
    Arch Otolaryngol Head Neck Surg; 2005 Mar 20; 131(3):198-203. PubMed ID: 15781758
    [Abstract] [Full Text] [Related]

  • 9. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn GS, Valanis B, Williams JH.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1743-50. PubMed ID: 15572756
    [Abstract] [Full Text] [Related]

  • 10. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.
    Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, Hennekens CH.
    Cancer; 1999 Nov 01; 86(9):1783-92. PubMed ID: 10547552
    [Abstract] [Full Text] [Related]

  • 11. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 01; 7(2):157-61. PubMed ID: 9488591
    [Abstract] [Full Text] [Related]

  • 12. The effect of folic acid on the development of stomach and other gastrointestinal cancers.
    Zhu S, Mason J, Shi Y, Hu Y, Li R, Wahg M, Zhou Y, Jin G, Xie Y, Wu G, Xia D, Qian Z, Sohg H, Zhang L, Russell R, Xiao S.
    Chin Med J (Engl); 2003 Jan 01; 116(1):15-9. PubMed ID: 12667380
    [Abstract] [Full Text] [Related]

  • 13. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
    Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ.
    N Engl J Med; 1990 Sep 20; 323(12):795-801. PubMed ID: 2202902
    [Abstract] [Full Text] [Related]

  • 14. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
    Kim ES, Hong WK.
    J Natl Cancer Inst; 2005 Apr 06; 97(7):468-70. PubMed ID: 15812064
    [No Abstract] [Full Text] [Related]

  • 15. Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
    Meyer F, Bairati I, Jobin E, Gélinas M, Fortin A, Nabid A, Têtu B.
    Nutr Cancer; 2007 Apr 06; 59(1):29-35. PubMed ID: 17927499
    [Abstract] [Full Text] [Related]

  • 16. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.
    Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G.
    N Engl J Med; 1990 Sep 20; 323(12):789-95. PubMed ID: 2202901
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
    Sackett MK, Bairati I, Meyer F, Jobin E, Lussier S, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B.
    Clin Cancer Res; 2008 Jan 01; 14(1):67-73. PubMed ID: 18172254
    [Abstract] [Full Text] [Related]

  • 18. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity.
    Cloos J, Bongers V, Lubsen H, Tobi H, Braakhuis BJ, Snow GB.
    Cancer Epidemiol Biomarkers Prev; 1996 Nov 01; 5(11):941-4. PubMed ID: 8922306
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].
    Bairati I, Brochet F, Roy J, Gélinas M, Nabid A, Têtu B, Mâsse B, Meyer F.
    Bull Cancer Radiother; 1996 Nov 01; 83(1):12-6. PubMed ID: 8679274
    [Abstract] [Full Text] [Related]

  • 20. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
    Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sánchez V, Garcia R, Buiatti E, Aebischer C, Franceschi S, Oliver W, Muñoz N.
    J Natl Cancer Inst; 2007 Jan 17; 99(2):137-46. PubMed ID: 17227997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.